Drug Trial Radar · NCT06470373
A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
Last checked: Nov 20, 2026Latest source record: Apr 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
434
Planned (sponsor's estimate)
Start
Jul 2025
Primary completion
Sep 2026
Study completion Sep 2026
Sponsor
- Lead sponsor
- Rophibio, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 24, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical study is designed to demonstrate the equivalence of the two Investigational Products by comparing the efficacy, safety, tolerability and immunogenicity of RBS-001 and Eylea® in subjects with Neovascular age-related macular degeneration.
Conditions
- Neovascular Age-related Macular Degeneration (nAMD)
Interventions
RBS-001 Solution for intravitreal injectionDrug
Administer 2 mg/eye (50 uL/eye) per dose of the IP via IVT to the subjects' study eye
Eylea® Solution for intravitreal injectionDrug
Administer 2 mg/eye (50 uL/eye) per dose of the IP via IVT to the subjects' study eye
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Best-Corrected Visual Acuity (BCVA) measured by Early treatment Diabetic Retinopathy Study (ETDRS) letter score at 8 weeks after the IP treatmentTime frame: The change from baseline (Day 1) to 8 weeks after the IP treatment
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Associated Retina Consultants - Phoenix
Phoenix, Arizona
Associated Retina Consultants - Gilbert
Phoenix, Arizona
Retina Partners of Northwest Arkansas, PLLC
Springdale, Arkansas
Erie Retina Research
Erie, Pennsylvania
Charles Retina Institute
Germantown, Tennessee
Retina Research Institute of Texas
Abilene, Texas
Strategic Clinical Research Group, LLC
Willow Park, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.